AXIM (AXIM Biotechnologies) Issuance of Debt: $0.67 Mil (TTM As of Jun. 2025)


What is AXIM Biotechnologies Issuance of Debt?

AXIM Biotechnologies AXIM -6.17% Issuance of Debt is $0.67 Mil as of Jun. 2025.

AXIM Biotechnologies's Issuance of Debt for the three months ended in Jun. 2025 was $0.67 Mil.

AXIM Biotechnologies's Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2025 was $0.67 Mil.

AXIM Biotechnologies Issuance of Debt Related Terms

AXIM Biotechnologies Issuance of Debt Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXIM Biotechnologies Issuance of Debt Chart

AXIM Biotechnologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 1.01 1.33 0.68 0.48

AXIM Biotechnologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.10 0.00 0.00 0.67

AXIM Biotechnologies Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of $0.67 Mil mean?
AXIM Biotechnologies (AXIM) has a Issuance of Debt of $0.67 Mil as of Jun. 2025. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on AXIM Biotechnologies and its competitors.
Is AXIM Biotechnologies' Issuance of Debt too high?
AXIM Biotechnologies' current Issuance of Debt is $0.67 Mil.
How does AXIM Biotechnologies' Issuance of Debt compare to ZVSA and HEPA?
AXIM Biotechnologies' Issuance of Debt of $0.67 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Biotechnology company?
A good Issuance of Debt depends on the Biotechnology industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on AXIM Biotechnologies and its competitors. AXIM Biotechnologies's current Issuance of Debt is $0.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXIM Biotechnologies stock overvalued right now?
AXIM Biotechnologies (AXIM) has a current Issuance of Debt of $0.67 Mil. The current Issuance of Debt is $0.67 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current Issuance of Debt is $0.67 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.